Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: J Hypertens. 2008 Nov;26(11):2121–2125. doi: 10.1097/HJH.0b013e32830fe4a5

Table 2.

Baseline Serum Sodium Concentrations and the Incidence of Blood Pressure Outcomes on Follow-up.

Baseline Follow-up
Serum Sodium Categories Men Women Mean Baseline Blood Pressure (mmHg) Increase in Blood Pressure Stage* Hypertension
n Median serum Sodium, meq/L (minimum, maximum) n Median serum Sodium, meq/L (minimum, maximum) Systolic Diastolic No. of events/No. at risk % (95% CI)* No. of events/No. at risk % (95% CI)
First (lowest) 227 136 (133–137) 278 137 (133–137) 115 75 197/505 39.0 (34.1, 44.1) 76/505 15.1 (11.7, 19.1)
Second 308 139 (138–139) 366 138 (138–139) 116 75 244/674 37.0 (32.6, 41.6) 100/674 15.2 (12.1, 19.0)
Third 162 140 (140–140) 188 140 (140–140) 117 76 123/350 35.5 (30.1, 41.2) 54/350 15.7 (11.8, 20.5)
Fourth (highest) 298 142 (141–145) 345 142 (141–145) 116 75 241/643 36.5 (32.1, 41.2) 88/643 13.2 (10.3, 16.7)

The 4 categories of serum sodium did not have equal numbers of participants (i.e., were not exact quartiles) because serum sodium concentrations were reported as whole numbers.

*

age- and sex-adjusted %; an increase in blood pressure stage was defined as an increment of at least one blood pressure category (as defined by the sixth report of the Joint National committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure).

age- and sex-adjusted %; Hypertension was defined as a systolic blood pressure of 140mm Hg or higher, a diastolic blood pressure of 90mm Hg or higher, or the use of antihypertensive medications.

HHS Vulnerability Disclosure